Term
|
Definition
|
|
Term
Bethanecol (Therapeutic class) |
|
Definition
Nonobstructive urinary retention agent |
|
|
Term
Bethanecol (therapeutic use) |
|
Definition
•To increase smooth muscle tone & contractions in GI tract after general anesthesia; treat nonobstructive urinary retention in patients with atony of the bladder. |
|
|
Term
Bethanecol (pharmacologic class) |
|
Definition
Muscarinic cholinergic receptor agonist |
|
|
Term
|
Definition
Direct-acting parasympathomimetic; muscarinic receptor agonist |
|
|
Term
|
Definition
|
|
Term
Atropine (therapeutic class) |
|
Definition
Antidote for anticholinesterase poisoning |
|
|
Term
Atropine (therapeutic use) |
|
Definition
To treat anticholinesterase poisoning |
|
|
Term
Atropine (pharmacologic class) |
|
Definition
Muscarinic cholinergic receptor antagonist |
|
|
Term
|
Definition
Muscarinic receptor antagonist |
|
|
Term
Phenylephrine (trade name) |
|
Definition
|
|
Term
Phenylephrine (therapeutic class) |
|
Definition
|
|
Term
Phenylephrine (therapeutic use) |
|
Definition
To reduce nasal congestion |
|
|
Term
Phenylephrine (pharm class)
|
|
Definition
|
|
Term
|
Definition
Nonselective alpha receptor agonist |
|
|
Term
|
Definition
|
|
Term
Prazosin (therapeutic class) |
|
Definition
|
|
Term
Prazosin (therapeutic use) |
|
Definition
In combination with other agents to treat hypertension |
|
|
Term
|
Definition
Adrenergic-blocking agent |
|
|
Term
|
Definition
Selective alpha-1 receptor antagonist |
|
|